|
The sample was not returned.The finished product met all specifications prior to being released for general distribution.The instructions for use which accompanies all devices currently addresses potential risks associated with surgically implanted materials.The instructions for use states in the adverse events: ¿complications associated with the proper implantation of the align¿ to urethral support system may include, but are not limited to: postoperative hematoma, which may occur following the implant procedure.Temporary urinary retention, bladder outlet obstruction, and voiding difficulties associated with over-correction/too much tension placed on the mesh sling implant.Perforations or lacerations of vessels, nerves, bladder or any viscera, which may occur during introducer needle passage.Transitory irritation at the operative wound site, which may elicit a foreign body response that leads to inflammation, infection, or erosion of the implant." 2993, 2348, 3274 ="nl".1750 = "l".
|
|
The patient's attorney alleged a deficiency against the device.Per additional information received, the patient has experienced constipation, mesh exposure, mesh erosion, recurrent bladder infections, 3 cm x 4 mm extrusion of mesh, extended spectrum beta-lactamases, burning, urgency, dysuria, cloudy urine, urinary frequency, cystocele, granulomatous reaction, vaginal mucosa, exhibiting mild fibrosis, inflammation of the submucosa, mesh pain, recurrent or worsening urinary incontinence, pain with intercourse, vaginal (apical) prolapse, pressure, vaginal fullness, needing to push near the anus or inside the vagina to evacuate bowel movements, slow urinary stream, trouble urinating, frequency and or urgency of urination, needing to push the bladder in to urinate, and irritation from prolapse beyond the opening of the vagina.The patient required additional surgical and non-surgical interventions.
|